[PDF][PDF] Breviscapine alleviates NASH by inhibiting TGF‐β‐activated kinase 1‐dependent signaling
T Lan, S Jiang, J Zhang, Q Weng, Y Yu, H Li… - …, 2022 - Wiley Online Library
Background and Aims NAFLD is a key component of metabolic syndrome, ranging from
nonalcoholic fatty liver to NASH, and is now becoming the leading cause of cirrhosis and …
nonalcoholic fatty liver to NASH, and is now becoming the leading cause of cirrhosis and …
[HTML][HTML] Breviscapine alleviates NASH by inhibiting TGF‐β‐activated kinase 1‐dependent signaling
T Lan, S Jiang, J Zhang, Q Weng, Y Yu… - Hepatology …, 2022 - ncbi.nlm.nih.gov
Breviscapine alleviates NASH by inhibiting TGF‐β‐activated kinase 1‐dependent signaling -
PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI …
PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI …
Breviscapine alleviates NASH by inhibiting TGF-β-activated kinase 1-dependent signaling.
T Lan, S Jiang, J Zhang, Q Weng, Y Yu, H Li… - Hepatology …, 2021 - europepmc.org
Breviscapine alleviates NASH by inhibiting TGF-β-activated kinase 1-dependent signaling. -
Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About …
Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About …
[HTML][HTML] Breviscapine alleviates NASH by inhibiting TGF‐β‐activated kinase 1‐dependent signaling
T Lan, S Jiang, J Zhang, Q Weng, Y Yu, H Li, S Tian… - Hepatology, 2022 - journals.lww.com
Breviscapine alleviates NASH by inhibiting TGF‐β‐activated k... : Hepatology Breviscapine
alleviates NASH by inhibiting TGF‐β‐activated kinase 1‐dependent signaling : Hepatology …
alleviates NASH by inhibiting TGF‐β‐activated kinase 1‐dependent signaling : Hepatology …
Breviscapine alleviates NASH by inhibiting TGF-β-activated kinase 1-dependent signaling
T Lan, S Jiang, J Zhang, Q Weng… - Hepatology …, 2022 - pubmed.ncbi.nlm.nih.gov
Background and aims NAFLD is a key component of metabolic syndrome, ranging from
nonalcoholic fatty liver to NASH, and is now becoming the leading cause of cirrhosis and …
nonalcoholic fatty liver to NASH, and is now becoming the leading cause of cirrhosis and …